Bryn Mawr Trust CO Glaukos Corp Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Glaukos Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 14 shares of GKOS stock, worth $1,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$1,313
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
345Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$754 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$561 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$194 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$181 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$137 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.47B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...